Collection of Efficacy and Safety Data of Chinese Patients Who Have Received Faslodex 250mg Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01425294
Recruitment Status : Terminated (The study has been decided to be early terminated for the FAS 500 mg has launched in 2015. The use mothod of 250mg per month in clinical practice is off-label.)
First Posted : August 30, 2011
Last Update Posted : December 5, 2017
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : January 30, 2016
  Actual Study Completion Date : January 30, 2016